Skip to main content
. 2018 Feb 8;15(4):4849–4858. doi: 10.3892/ol.2018.7995

Figure 7.

Figure 7.

Subcutaneous injection of GC cells into NOD/SCID mice led to primary tumor development at the site of injection. Histological analysis of section stained with hematoxylin and eosin of tumor established in NOD/SCID is presented (A) GC1401, (B) GC1415 and (C) GC1436. Magnification ×200. NOD/SCID, non-obese diabetic/severe combined immunodeficiency.